title: [Adjuvant treatment of anisodamine to acute serous otitis media].
abstract: OBJECTIVE
  To evaluate the adjuvant treatment of anisodamine to acute serous otitis media.
  
  
  METHODS
  Sixty-one acute otitis media patients were divided randomly into two groups. Group A with 30 patients were treated with 1% ephedrine nosedrop, antibiotic and antihistamine. Group B with 30 patients were treated with 1% ephedrine nose drops, antibiotic, antihistamine and anisodamine. They took anisodamine 10 mg twice a day. Then the treating efficiency of group A was compared with that of group B in 5 days and 10 days respectively.
  
  
  RESULTS
  The symptoms including hearing loss, tinnitus, hydrotympanum and eustachian tube function of group B recover more guickly than that of group A.
  
  
  CONCLUSIONS
  Anisodamine adjuvant treatment of acute serous otitis media by improving the function of eustachian tube and microcirculation.
authors.affiliation: Department of Otolaryngology, PUMC Hospital, CAMS and PUMC, Beijing, 100730, China.
authors.forename: Zidong
authors.initials: Z
authors.lastname: Jiang
authors.forename: Wen
authors.initials: W
authors.lastname: Liu
authors.forename: Cuixia
authors.initials: C
authors.lastname: Zhao
authors.forename: Lianshan
authors.initials: L
authors.lastname: Zhang
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010034:Otitis Media with Effusion / Q000188:drug therapy*; D012991:Solanaceous Alkaloids / Q000627:therapeutic use*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D012991:Solanaceous Alkaloids; C003922:anisodamine